Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.

Copy For Citation

Gungordu S., Aptullahoglu E.

Investigational new drugs, 2024 (SCI-Expanded)

• Publication Type: Article / Article
• Volume:
• Publication Date: 2024
• Doi Number: 10.1007/s10637-024-01473-9
• Journal Name: Investigational new drugs
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, ABI/INFORM, BIOSIS, Biotechnology Research Abstracts, CINAHL
• Bilecik Şeyh Edebali University Affiliated: Yes